Clover Biopharmaceuticals Shares Fall on Hong Kong Debut
Clover Biopharmaceuticals Shares Fall on Hong Kong Debut - Chinese Covid-19 vaccine developer raises $240 million to fund development and commercialization of its product
Stay updated with breaking news from Bob Simison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clover Biopharmaceuticals Shares Fall on Hong Kong Debut - Chinese Covid-19 vaccine developer raises $240 million to fund development and commercialization of its product
Asia-Middle East Digital Currency Trial Reports Progress - Experiment involving central banks and financial institutions from China, the UAE, Hong Kong and Thailand completed $312 million of cross-border transactions
SPAC Listing Plan in Hong Kong Wins Advisory Panel Backing - Blank-check special purpose acquisition companies would face strict rules after HK exchange’s struggles with shell company scandals
China’s Coal Futures Continue Dropping Amid Price Cap Talk - Wednesday decline of 10% drives the most-active thermal coal contract down 30.5% in a week as economic planners target even lower prices to ease the power crunch
Hong Kong Luxury Villa Linked to Evergrande’s Hui Pledged for Loan - Billionaire founder of debt-laden developer comes under increasing pressure to tap into his personal wealth in addressing crisis